Zolmitripan uptake by human intestinal epithelial Caco-2 cells

Pharmazie

Volumn 61, Issue 10, 2006, Pages 862-865

  Yu, L S ^a   Zhao, N P ^a   Yao, T W ^a   Zeng, Su ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMILORIDE; FLUNARIZINE; GLYCOPROTEIN P; NIFEDIPINE; NIMODIPINE; PROPAFENONE; PROPRANOLOL DERIVATIVE; SUMATRIPTAN; VERAPAMIL; ZOLMITRIPTAN; OXAZOLIDINONE DERIVATIVE; SEROTONIN AGONIST; TRYPTAMINE DERIVATIVE;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTESTINE CELL; INTESTINE EPITHELIUM CELL; PH; TEMPERATURE DEPENDENCE; ABSORPTION; DOSE RESPONSE; DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; TEMPERATURE;

ABSORPTION; CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; OXAZOLIDINONES; SEROTONIN AGONISTS; TEMPERATURE; TRYPTAMINES;

EID: 33750371051     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Crowe A, Wong P (2004) pH Dependent uptake of Ioperamide across the gastrointestinal tract: an in vitro study. Drug Dev Ind Pharm 30: 449-459.
2. Evans DC, O'Connor D, Lake BG (2003) Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein. Drug Metab Dispos 31: 861-869.
3. Fogh J, Fogh MJ, Orfe T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors nude mice. Natl Cancer Inst 59: 221-226.
4. Hidalgo IJ, Raub TJ, Borchardt RT (1989) Characterization of human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96: 736-749.
5. Hilgers AR, Conradi RA, Burton PS (1990) Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 7: 902-910.
6. Jiunn HL (2003) Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv Drug Deliv Rev 55: 53-81.
7. Katsarava Z, Limmroth V (2004) Differences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks. Cephalalgia 24: 657-666.
8. Kim RB, Wandel C, Leake B (1999) Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res 16: 408-414.
9. Lewis D, Ashwal S, Hershey A (2004) Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63: 2215-2224.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall J (1951) Protein measurement with the Folin phenol regent. J Biol Chem 193: 265-275.
11. Peck RW, Seaber EJ, Dixon R (1997) The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90). Br J Clin Pharmacol 44: 595-599.
12. 2+ channel blockers to enhance inhibition by taxol of growth of drug-sensitive and resistant Chinese hamster ovary cells. Cancer Treat Rep 70: 275-278.
13. Schmid D, Ecker G, Kopp S, Hitzler M, Chiba P (1999) Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements. Biochem Pharmacol 58: 1447-1456.
14. Schoenen J, Sawyer J (1997) A novel dual central and peripheral 5HT1B/ID agonist: an overview of efficacy. Cephalalgia 17: 28-40.
15. Seaber E, Phillips S (1996) The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers. Br J Clin Pharmacol 41: 141-147.
16. Seaber EJ, Peck RW (1998) The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan inhealthy volunteers. Br J Clin Pharmacol 46: 433-439.
17. Tsuji A, Takanaga H (1994) Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm. Res 11: 30-37.
18. Wang YF, Renee A, Francis LT (1997) Absorption of D-glucose in the rat studied using in situ intestinal perfusion: a permeability-index approach. Pharm Res 14: 1563-1567.
19. Whale R, Bhagwagar Z (1999) Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors. Psychopharmacology 145: 223-226.
20. Yu LS, Yao TW, Zeng S (2003) In vitro metabolism of zolmitriptan in rat cytochromes induced with β-naphthoflavone and the interaction between six drugs and zolmitriptan. Chem-Biol Interact 146: 263-272.
21. Zhang L, Liu XD, Xie L, Wang GJ (2003) P-glycoprotein restricted transport of nimodipine across blood-brain barrier. Acta Pharmacol Sin 24: 903-906.